T cell therapies have revolutionized cancer treatment—but so far, their success has been largely limited to blood cancers. Solid tumors, which account for around 90% of all adult cancers, remain a ...

Automotive survival has become a test of adaptability and innovation. This review identifies which brands are losing that race; tracing their downfall through production data, battery tech setbacks, ...

Azalea's first drug candidate is a CAR-T therapy for cancer and autoimmune conditions that turns immune cells into cancer ...

Energy Innovation, a think tank, found that repealing tailpipe standards could cost households an extra $310 billion by 2050, ...

To make the therapy safer and more adaptable, UChicago researchers developed a new “split” system called GA1CAR. This uses ...

Elon Musk says Tesla is “getting close” to unveiling a prototype with “crazy technology,” fueling speculation about a ...

For decades, doctors believed the best way to prevent peanut allergies was to keep young children away from peanuts entirely, but new research shows that advice was completely wrong ...

Whether you’ve lived here your whole life, you’re just visiting, or maybe thinking of moving to St. Louis, you might be ...

A new West Coast biotech has emerged into the busy in vivo cell therapy space, this time with the backing of Nobel Prize-winning CRISPR pioneer Jennifer Doudna, Ph.D. Azalea Therapeutics has bloomed ...

Steven Jordan, who was hired as Sonoma Valley Unified School District’s director of maintenance, operations and ...

The funding represents Trump’s latest attempt at coal revitalization, but updating the nation’s aging facilities would cost ...